GEN Exclusives

More »

GEN Exclusives

GEN Exclusives provide you with unique, in-depth, and critical coverage of key industry developments, market moving events, and scientific advances, as well as interviews with life science thought leaders. Also included are feature articles from GEN’s print edition.

Insight & Intelligence™: Aug 27, 2014

Infographic: Biotherapeutics — Putting Patients First

Learn more about the manufacturing process of biotherapeutics and the current challenges they face in this graphic from the International Federation for Pharmaceutical Manufactures and Associations (IFPMA).

Infographic: Biotherapeutics — Putting Patients First

    Undoubtedly, one innovation that has radically transformed medicines is the development of newer, more sophisticated type of drugs produced by living organisms called biotherapeutics. More than 350 biotherapeutic medicines have benefited to date some 400 million patients worldwide. Biotherapeutics lead to more targeted therapies, better diagnostics, and improved outcomes following a patient’s course of treatment for many of the world’s most prevalent diseases, as well as for less common conditions.

    Biotherapeutics include innovative products for the treatment of chronic diseases such as cancer, diabetes, and rheumatoid arthritis, as well as for acute conditions such as myocardial infarction and stroke—and have two common denominators: biological origin and structural complexity. These products bring genuine differences in saving lives, reducing hospitalization, and, ultimately, contributing to healthier societies. 

    The above infographic is brought to you by IFPMA. (If you're having trouble reading the infographic, click here.)

Add a comment

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?